Nasdaq Copenhagen A/S: Veloxis Pharmaceuticals A/S - admittance to trading and official listing of new shares due to exercise of employee warrants

The share capital of Veloxis Pharmaceuticals has been increased. The admittance
to trading and official listing of new shares will take effect on 4 January
2019 in the ISIN below. 



ISIN:                  DK0060048148                             
----------------------------------------------------------------
Name:                  Veloxis Pharmaceuticals                  
----------------------------------------------------------------
Volume before change:  1,717,786,586 shares (DKK 171,778,658.60)
----------------------------------------------------------------
Change:                408,762 shares (DKK 40,876.20)           
----------------------------------------------------------------
Volume after change:   1,718,195,348 shares (DKK 171,819,534.80)
----------------------------------------------------------------
Subscription price:    DKK 0.35 - 366,700 shares                
                       DKK 0.95 - 42,062 shares                 
----------------------------------------------------------------
Denomination:          DKK 0.10                                 
----------------------------------------------------------------
Short name:            VELO                                     
----------------------------------------------------------------
Orderbook ID:          36992                                    
----------------------------------------------------------------



For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33
93 34 60

Attachment:
https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=704710